ArticleCanadian journal of gastroenterology & hepatology2018

RAS/BRAF Circulating Tumor DNA Mutations as a Predictor of Response to First-Line Chemotherapy in Metastatic Colorectal Cancer Patients.

Jiannan Yao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.